Cargando…
A possible protective role for Bacillus Calmette-Guérin therapy in urinary bladder cancer in the era of COVID-19: a brief report
Given the systemic immunogenic effects of Bacillus Calmette-Guérin (BCG) therapy in patients with bladder cancer and its non-specific immunogenic effects in viral respiratory diseases, we aimed to study severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in bladder cancer patients...
Autores principales: | Ohadian Moghadam, Solmaz, Abbasi, Behzad, Nowroozi, Ali, Amini, Erfan, Nowroozi, Mohammad Reza, Momeni, Seyed Ali, Niroomand, Hassan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Vaccine Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217577/ https://www.ncbi.nlm.nih.gov/pubmed/34222132 http://dx.doi.org/10.7774/cevr.2021.10.2.191 |
Ejemplares similares
-
Association of human papilloma virus (HPV) infection with oncological outcomes in urothelial bladder cancer
por: Ohadian Moghadam, Solmaz, et al.
Publicado: (2020) -
Severity of COVID-19 in bacillus Calmette-Guérin vaccinated population
por: Khanum, Iffat, et al.
Publicado: (2021) -
Radical cystectomy for management of inflammatory myofibroblastic tumor of the urinary bladder: A rare case report
por: Ayati, Mohsen, et al.
Publicado: (2019) -
Coinfection of Tuberculosis Pneumonia and COVID-19 in a Patient Vaccinated with Bacille Calmette-Guérin (BCG): Case Report
por: Luciani, Michelangelo, et al.
Publicado: (2020) -
Lessons From Bacille Calmette-Guérin for SARS-CoV-2 Vaccine Candidates
por: Behr, Marcel A, et al.
Publicado: (2020)